ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153353 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153353; 2) Community: the network communities that were significantly associated with the response to NSC 153353; 3) Molecule: the relationships between components within communities and NSC 153353; 4) MDR: the compounds that were significantly associated with the NSC 153353.

NSC Compound Enrichment Correlation
NSC 382035 2,4-Pyrimidinediamine, 6-ethyl-5-[4-[methyl(phenylmethyl) amino]-3-nitrophenyl]- 0.000108967261726037 0.56112104
NSC 744231 Null 0.00014759055644977 0.3753115
NSC 755417 Null 0.00014759055644977 0.44148161
NSC 331121 NIVEUSIN A 0.000217933685920728 -0.12025896
NSC 740 Methotrexate 0.000217933685920728 0.52708737
NSC 728087 Bis-{(5,6-dihydro-5,11-diketo-11H-indeno[1,2-c]isoquinoline) -6-ethylamino}propane Bis(trifluoroacetate) 0.000220702896059653 0.23755801
NSC 754735 Null 0.000220702896059653 0.44049529
NSC 58906 9H-Purine, 6-[(o-chlorobenzyl)thio]-9-(2-chloroethyl)- (8CI) 0.000323852502732644 0.51207306
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.000323852502732644 0.47727042
NSC 717842 Acetamide, 2-[[[2-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)- 1,2-dihydro-3H-indol-3-ylidene]amino]oxy]-, (2Z)- 0.000323852502732644 0.32238538
Total:92  Current:1    [First] [Prev] [Next] [Last]